PB
Protalix Biotherapeutics Inc
🇺🇸XNYS.PLXUnited StatesHealthcare
$2.67USDdown -0.10 (-3.61%)OpenEnd of day6:54 PM
Price$2.67-0.10 (-3.61%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US74365A3095
- CUSIP
- 74365A309
Company
- Employees
- 226
- Headquarters
- Hackensack, United States
- Website
- https://www.protalix.com
- CEO
- Mr. Dror Bashan
Market
- Shares outstanding
- 80.6M
- Market cap
- $215.13M
Highlights
- Market cap
- $215.13M
- EPS LTM
- $0.18
- P/E LTM
- 11.86
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $76.38M+27.8%up year on year
- Net income
- $15.33M+292.32%up year on year
- Gross margin
- 69.97%+40%up year on year
- Free cash flow
- $14.64M+1,036.94%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.